Nanchang Anobri Pharmaceutical CO., LTD Building B1, No. 888, Jingkai Avenue
FDA inspection history across 2 sites, 2023
- 2
- Form 483s
Every document, by year
- Form 483
2023: two Form 483s.
The story so far
Built from the dates and citations on the documents themselves.
- 2023Two Form 483s, at Nanchang, China and Nanchang City, China.
- 2023The longest 483 on file: 12 observations over 8 pages at Nanchang, China.
Cited most
Across all Nanchang Anobri Pharmaceutical CO., LTD Building B1, No. 888, Jingkai Avenue observations on file
- 21 CFR 211.160General requirements3
- 21 CFR 211.22(d)Responsibilities of quality control unit2
- 21 CFR 820.30(b)Design controls2
- 21 CFR 211.188Batch production and control records1
- 21 CFR 211.67(b)(1)Equipment cleaning and maintenance1
The complete Nanchang Anobri Pharmaceutical CO., LTD Building B1, No. 888, Jingkai Avenue file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Nanchang, China
One Form 483 · 2023 · 12 observations
Latest: Form 483, Nov 21, 2023 →Nanchang City, China
One Form 483 · 2023 · 2 observations
Latest: Form 483, Nov 21, 2023 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-11-21 | 483 Form 483 | Nanchang, China | 12 | $99 |
| 2023-11-21 | 483 Form 483 | Nanchang City, China | 2 | $99 |
Investigators on these documents
Janete F. Guardia (2)Dennis Cantellops (1)Dennis Cantellops Paite (1)
FEI number 3023765884 · most recent document Nov 21, 2023
About Nanchang Anobri Pharmaceutical CO., LTD Building B1, No. 888, Jingkai Avenue
How many FDA Form 483s has Nanchang Anobri Pharmaceutical CO., LTD Building B1, No. 888, Jingkai Avenue received?
FDA Intel has 2 Form 483s on file for Nanchang Anobri Pharmaceutical CO., LTD Building B1, No. 888, Jingkai Avenue; the most recent is dated Nov 21, 2023.
When was Nanchang Anobri Pharmaceutical CO., LTD Building B1, No. 888, Jingkai Avenue last inspected by FDA?
The most recent FDA inspection document on file for Nanchang Anobri Pharmaceutical CO., LTD Building B1, No. 888, Jingkai Avenue is a Form 483 dated Nov 21, 2023, for the site in Nanchang, China.
What did FDA cite at Nanchang Anobri Pharmaceutical CO., LTD Building B1, No. 888, Jingkai Avenue?
The regulations cited most in the observations on file for Nanchang Anobri Pharmaceutical CO., LTD Building B1, No. 888, Jingkai Avenue are 21 CFR 211.160 (General requirements), 3 times; 21 CFR 211.22(d) (Responsibilities of quality control unit), 2 times; 21 CFR 820.30(b) (Design controls), 2 times.